Sanofi MS treatment Aubagio slows brain atrophy in Phase III trial
October 7, 2015Research and Development Genzyme, MS, Sanofi
Sanofi and its subsidiary Genzyme have announced that magnetic resonance imaging (MRI) data from the Phase III TEMSO study demonstrate …
FDA approves Alkermes schizophrenia treatment
October 6, 2015Research and Development Alkermes, Aristada, FDA, schizophrenia
The US Food and Drug Administration (FDA) has approved Alkermes’s Aristada (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizophrenia. Aristada …
Flu jab reduces risk of stroke for two months
October 6, 2015Research and Development flu vaccine, stroke
The risk of suffering a stroke is significantly reduced for up to two months after receiving a flu vaccine, a …
Moving forward in diabetes
October 6, 2015Research and Development Novo Nordiak, diabetes
As many as 387 million people worldwide are living with diabetes, and it is predicted that by 2035 more than …
Novo Nordisk and Diabetes UK extend ‘Clinical Champions’ initiative
October 6, 2015Medical Communications Novo Nordisk, diabetes
Diabetes UK and Novo Nordisk have announced the appointment of 20 Diabetes UK ‘Clinical Champions’, who will be supported and …
David Luther joins MISSION Therapeutics
October 6, 2015Manufacturing and Production, Medical Communications, Sales and Marketing
Cambridge, UK-based MISSION Therapeutics has announced the appointment of David Luther as chief financial officer.Luther brings more than 25 years’ …
Baxter recalls saline after mould contamination
October 6, 2015Manufacturing and Production baxter
Following a number of recalls earlier this year, Baxter has recalled potentially a further 140,000 bags of sodium chloride due …
UK tops Quality of Death rankings
October 6, 2015Medical Communications NHS, ageing population, palliative care
The UK has ranked first in the 2015 Quality of Death Index, a measure of the quality of palliative care …
Cardinal Health completes $1.944bn acquisition of J&J’s Cordis
October 6, 2015Manufacturing and Production, Sales and Marketing Cardinal Health, Cordis, mergers and acquisitions
Cardinal Health has completed the acquisition of Johnson & Johnson’s Cordis business: a global leader in cardiology and endovascular devices, …
Pfizer axes lay-off plans and creates new jobs
October 6, 2015Manufacturing and Production Pfizer
A Pfizer facility in Ireland that was set to close has now been taken off the list of facilities no longer needed …
Desktop device synthesising lidocaine could revolutionise pharma manufacturing
October 6, 2015Manufacturing and Production lidocaine
A novel device with the ability to produce one of the most in-demand anaesthetics in any location may set the …
After Daraprim, Turing Pharma submits first in-house candidate to FDA
October 6, 2015Manufacturing and Production, Research and Development turing
Turing Pharma may have been on the end of some less-than-favourable media coverage in recent weeks, but the company is …
Teva acquires Mexico’s Rimsa for $2.3 billion
October 5, 2015Research and Development, Sales and Marketing Mexico, Rimsa, Teva, mergers and acquisitions
Strategic Move Enhances Teva’s Presence in Mexico, the Second Largest Market in Latin America and a Major Emerging Market Brings a Portfolio of …
North 51 acquired by Bionical
October 5, 2015Bionical, North 51, mergers and acquisitions
North 51 Ltd, a Nottingham-based healthcare company has been acquired by Bionical in a multi-million pound deal. The North 51 …
Why London is at the heart of life sciences
October 5, 2015Research and Development NHS
by Eliot ForsterWhatever disease you’re trying to cure, you can bet that somebody in London has it. That probably isn’t …
FDA approves Merck’s Keytruda for advanced NSC lung cancer
October 5, 2015Research and Development, Sales and Marketing BMS, NSCL, keytruda, lung cancer, merck sharp and dohme, opdivo
The US Food and Drug Administration has granted accelerated approval for Merck’s Keytruda (pembrolizumab) to treat patients with advanced (metastatic) …
Pfizer completes $130 million purchase of two GSK vaccines
October 5, 2015Sales and Marketing GSK, Pfizer, meningitis
Pfizer has announced that it has completed the $130 million acquisition of GlaxoSmithKline’s quadrivalent meningococcal ACWY vaccines Nimenrix and Mencevax. …
David Cameron pledges seven-day GP service by 2020
October 5, 2015Medical Communications NHS, david cameron
Millions of patients will benefit from ground-breaking plans for seven-day access to both their GPs and hospitals, British Prime Minister …
Hillary Clinton takes aim at pharma industry in White House bid
October 5, 2015Medical Communications, Sales and Marketing turing
Hillary Clinton has taken aim at the pharmaceutical industry with a campaign advert airing in two US states, in which …
New partnership will speed medical diagnoses through crowdsourcing
October 5, 2015Medical Communications, Sales and Marketing Global Genes, Sermo
The global social network for physicians, SERMO, is partnering with Global Genes, a leading rare disease patient advocacy organisation, to provide …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
